Chadwick, A. C., Wang, X., & Musunuru, K. (2017). In Vivo Base Editing of PCSK9 as a Therapeutic Alternative to Genome Editing. Arterioscler Thromb Vasc Biol.
Chicago ZitierstilChadwick, Alexandra C., Xiao Wang, und Kiran Musunuru. "In Vivo Base Editing of PCSK9 As a Therapeutic Alternative to Genome Editing." Arterioscler Thromb Vasc Biol 2017.
MLA ZitierstilChadwick, Alexandra C., Xiao Wang, und Kiran Musunuru. "In Vivo Base Editing of PCSK9 As a Therapeutic Alternative to Genome Editing." Arterioscler Thromb Vasc Biol 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.